» Articles » PMID: 30454753

Lupus Nephritis

Overview
Specialty Pediatrics
Date 2018 Nov 21
PMID 30454753
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Childhood-onset systemic lupus erythematosus (SLE) is a subset of SLE with an onset before 18 years of age. Patients with early onset SLE tend to have a greater genetic component to their disease cause, more multisystemic involvement, and a more severe disease course, which includes greater risks for developing nephritis and end-stage kidney disease. Five- and 10-year mortality is lower than in adult-onset SLE. Although patient and renal survival have improved with advances in induction and maintenance immunosuppression, accumulation of irreversible damage is common. Cardiovascular and infectious complications are frequent, as are relapses during adolescence and the transition to adulthood.

Citing Articles

Progress of rituximab in the treatment of systemic lupus erythematosus and lupus nephritis.

Mo S, Li Y, He J, Lin L Front Med (Lausanne). 2024; 11:1472019.

PMID: 39430591 PMC: 11486751. DOI: 10.3389/fmed.2024.1472019.


Biologicals for the treatment of lupus nephritis: a Bayesian network meta-regression analysis.

Liu X, Chen X, Yang C, Li R, Chen X, Li Q Front Immunol. 2024; 15:1445814.

PMID: 39281677 PMC: 11392858. DOI: 10.3389/fimmu.2024.1445814.


[Correlation of anti-C1q antibodies with active systemic lupus erythematosus and lupus nephritis in children].

Li Y, Yang J, Zhang Y, Cao Y, Li X, Shuai L Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(8):835-839.

PMID: 39148388 PMC: 11334543. DOI: 10.7499/j.issn.1008-8830.2404159.


Remission and long-term remission of pediatric-onset systemic lupus erythematosus.

Chen Y, Hsu C, Tsai M, Fu L, Huang Y Front Pediatr. 2023; 11:1272065.

PMID: 37964813 PMC: 10641753. DOI: 10.3389/fped.2023.1272065.


Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis.

Jiang N, Jin S, Yu C, Zhao J, Wang Q, Tian X Front Immunol. 2023; 14:1232244.

PMID: 37901212 PMC: 10611487. DOI: 10.3389/fimmu.2023.1232244.